Palbociclib Hydrochloride
Palbociclib Hydrochloride, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Palbociclib Hydrochloride - API Standards
[catalogue_number] => PA 16 3010000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 484
[form] => C24H30ClN7O2
[cas] => 827022-32-2
[pslug] => 827022-32-2-palbociclib-hydrochloride-api-pa163010000
[latest_product] => 0
[linkproducts] => 1
[offers_id] => 1
[offers_name] => Spring Season Offer
[offers_status] => 1
[offers_start_date] => 2024-03-27
[offers_end_date] => 2024-03-31
[pageview] => 2
[offers_slug] => spring-season-offer
[offers_product_id] => 3669
[offers_product_code] => PA 16 3010000
[offers_master_id] => 1
[offer_percentage] => 20% OFF
[offers_product_main_cat] => Pharmaceutical Reference Standards
)
Palbociclib Hydrochloride - API Standards